Recent Advances and Future Frontiers in Treating Age-Related Cataracts

JAMA

Volumn 290, Issue 2, 2003, Pages 248-251

  Solomon, Renée ^a,c   Donnenfeld, Eric D ^b  

^a OPHTHALMIC CONSULTANTS OF LONG ISLAND   (United States)

^b EAR AND THROAT HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GATIFLOXACIN; KETOROLAC TROMETAMOL; MOXIFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE ACETATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID;

CATARACT; CATARACT EXTRACTION; COMORBIDITY; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; ELDERLY CARE; HUMAN; INFECTION; INFECTION PREVENTION; INFLAMMATION; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; RETINA MACULA DEGENERATION; REVIEW; SYMPTOMATOLOGY; TREATMENT INDICATION; VISUAL DISORDER; AGED; CLASSIFICATION; ELECTROCARDIOGRAPHY; FEMALE; MALE; METHODOLOGY; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; PREOPERATIVE CARE; RISK ASSESSMENT; STANDARD;

AGED; CATARACT; CATARACT EXTRACTION; COMORBIDITY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; PREOPERATIVE CARE; RISK ASSESSMENT;

EID: 0038013892     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.2.248     Document Type: Review

References (49)

1. Yorston D. A perspective from a surgeon practicing in the developing world. Surv Ophthalmol. 2000;45:S1-S2.
2. Brian G, Taylor H. Cataract blindness: challenges for the 21st century. Bull World Health Organ. 2001;79:249-256.
3. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 1991;325:1412-1417.
4. Muñoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation study. Arch Ophthalmol. 2000;118:819-825.
5. Lens and Cataract: Section 11 Basic and Clinical Science Series. San Francisco, Calif: Foundation of the American Academy of Ophthalmology; 2000.
6. Hammond CJ, Snieder H, Spector TD, Gilbert CE. Genetic and environmental factors in age-related nudear cataracts in monozygotic and dizygotic twins. N Engl J Med. 2000;342:1786-1790.
7. Livingston PM, Carson CA, Taylor HR. The epidemiology of cataract: a review of the literature. Ophthalmic Epidemiol. 1995;2:151-164.
8. West SK, Muñoz B, Schein OD, et al. Racial differences in lens opacities: the Salisbury Eye Evaluation (SEE) project. Am J Epidemiol. 1998;148:1033-1039.
9. Leske MC, Wu SY, Hennis A, et al. Diabetes, hypertension, and central obesity as cataract risk factors in a black population: the Barbados Eye Study. Ophthalmology. 1999;106:35-41.
10. Muñoz B, Tajchman U, Bochow T, West S. Alcohol use and risk of posterior subcapsular opacities. Arch Ophthalmol. 1993;111:110-112.
11. Cumming RG, Mitchell P. Alcohol, smoking, and cataracts: the Blue Mountains Eye Study. Arch Ophthalmol. 1997;115:1296-1303.
12. Jick SS, Vasilakis-Scaramozza C, Maier WC. The risk of cataract among users of inhaled steroids. Epidemiology. 2001;12:229-234.
13. Garbe E, Suissa S, LeLorier J. Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA. 1998;280:539-543.
14. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med. 1997;337:8-14.
15. Kador PF. Overview of the current attempts toward the medical treatment of cataract. Ophthalmology. 1983;90:352-364.
16. Fisher SJ, Cunningham RD. The medical profile of cataract patients. Clin Geriatr Med. 1985;1:339-344.
17. Gilvarry A, Eustace P. The medical profile of cataract patients. Trans Ophthalmol Soc U K. 1982;102:502-504.
18. Bass EB, Steinberg EP, Luthra R. Do ophthalmologists, anesthesiologists, and internists agree about preoperative testing in healthy patients undergoing cataract surgery? Arch Ophthalmol. 1995;113:1248-1256.
19. Schein OD, Katz J, Bass EB, et al. The value of routine preoperative medical testing before cataract surgery. N Engl J Med. 2000;342:168-175.
20. Koch PS. Simplifying Phacoemulsification. 5th ed. Thorofare, NJ: Slack Inc; 1997.
21. Leaming DV. Practice styles and preferences of ASCRS members: 2001 survey. J Cataract Refract Surg. 2002;28:1681-1688.
22. Kelman CD. Phacoemulsification and aspiration: a new technique of cataract removal. Am J Ophthalmol. 1967;64:23-55.
23. Dodick JM, Sperber LTD. The future of cataract surgery. Int Ophthalmol Clin. 1994;34:201-210.
24. Castells X, Comas M, Castilla M, et al. Clinical outcomes and costs of cataract surgery performed by planned ECCE and phacoemulsification. Int Ophthalmol. 1998;22:363-367.
25. Kraff MC, Sanders DR. Planned extracapsular extraction versus phacoemulsification with IOL implantation. J Am Intraocul Implant Soc. 1982;8:38-41.
26. Fine IH, Hoffman RS. Clear corneal cataract surgery. Ophthalmic Surg Lasers. 1998;29:822-831.
27. Gills JP, Cherchio M, Raanan MG. Unpreserved lidocaine to control discomfort during cataract surgery using topical anesthesia. J Cataract Refract Surg. 1997;23:545-550.
28. Koch PS. Anterior chamber irrigation with unpreserved lidocaine 1% for anesthesia during cataract surgery. J Cataract Refract Surg. 1997;23:551-554.
29. Patel BC, Burns TA, Crandall A. A comparison of topical and retrobulbar anesthesia for cataract surgery. Ophthalmology, 1996;103:1196-1203.
30. McLemore CS. Aphakic correction from an aphake's point of view [letter]. Arch Ophthalmol. 1965;74:443.
31. Vargas LG, Peng Q, Escobar-Gomez M, et al. Overview of modern foldable intraocular lenses and clinically relevant anatomy and histology of the crystalline lens. Int Ophthalmol Clin. 2001;41:1-15.
32. Apple DJ, Sims J. Harold Ridley and the invention of the intraocular lens. Surv Ophthalmol. 1996;40:279-292.
33. Javitt JC, Steinert RF. Cataract extraction with multifocal intraocular lens implantation. Ophthalmology. 2000;107:2040-2048.
34. Steinert RF, Aker BL, Trentacost DJ, et al. A prospective comparative study of the AMO ARRAY zonalprogressive multifocal silicone intraocular lens and a monofocal intraocular lens. Ophthalmology. 1999;106:1243-1255.
35. Jaffee NS, Jaffee MS, Jaffee GF. Cataract Surgery and Its Complications. 6th ed. St Louis, Mo: Mosby; 1997.
36. Schmidbauer JM, Vargas LG, Peng Q, et al. Postedor capsule opacification. Int Ophthalmol Clin. 2001;41:109-131.
37. Kruger AJ, Schauersberger J, Abela C, et al. Two year results: sharp versus rounded optic edges on silicone lenses. J Cataract Refract Surg. 2000;26:566-570.
38. Olson RJ, Crandall AS. Silicone versus polymethylmethacrylate intraocular lenses with regard to capsular opacification. Ophthalmic Surg Lasers. 1998;29:55-58.
39. Hollick EJ, Spalton DJ, Ursell PG, et al. Posterior capsular opacification with hydrogel, polymethylmethacrylate, and silicone intraocular lenses. Am J Ophthalmol. 2000;129:577-584.
40. Steinberg EP, Tielsch JM, Schein OD, et al. National study of cataract surgery outcomes. Ophthalmology. 1994;101:1131-1140.
41. Owsley C, McGwin G, Sloane M, et al. Impact of cataract surgery on motor vehicle crash involvement by older adults. JAMA. 2002;288:841-849.
42. Tielsch JM, Steinberg EP, Cassard SD, et al. Preoperative functional expectations and postoperative outcomes among patients undergoing first eye cataract surgery. Arch Ophthalmol. 1995;113:1312-1318.
43. Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14: an index of functional impairment in patients with cataract. Arch Ophthalmol. 1994;112:630-638.
44. Schein OD, Steinberg EP, Cassard SD, et al. Predictors of outcome in patients who underwent cataract surgery. Ophthalmology. 1995;102:817-823.
45. Sugar A, Schertzer RM. Clinical course of phacoemulsification wound burns. J Cataract Refract Surg. 1999;25:688-692.
46. Fine IH, Packer M, Hoffman RS. New phacoemulsification technologies. J Cataract Refract Surg. 2002;28:1054-1060.
47. Nanevicz TM, Prince MR, Gawande AA, Puliafito CA. Excimer laser ablation of the lens. Arch Ophthalmol. 1986;104:1825-1829.
48. Soscia W, Howard JG, Olson RJ. Microphacoemulsification with WhiteStar: a wound-temperature study. J Cataract Refract Surg. 2002;28:1044-1046.
49. Donnenfeld ED, Olson RJ, Solomon R, et al. Efficacy and wound temperature gradient of WhiteStar technology phacoemulsification through a 1.2 mm incision J Cataract Refract Surg. 2003;29:1097-1100.